Your browser is no longer supported. Please, upgrade your browser.
Autolus Therapeutics plc
Index- P/E- EPS (ttm)-2.74 Insider Own31.86% Shs Outstand52.04M Perf Week-1.79%
Market Cap454.02M Forward P/E- EPS next Y-2.65 Insider Trans0.00% Shs Float8.82M Perf Month3.79%
Income-130.10M PEG- EPS next Q-0.77 Inst Own24.20% Short Float8.00% Perf Quarter-25.68%
Sales1.20M P/S378.35 EPS this Y-448.30% Inst Trans0.29% Short Ratio4.03 Perf Half Y-39.01%
Book/sh4.98 P/B1.76 EPS next Y0.70% ROA-41.10% Target Price- Perf Year-12.21%
Cash/sh4.10 P/C2.14 EPS next 5Y- ROE-48.60% 52W Range3.00 - 17.19 Perf YTD-1.90%
Dividend- P/FCF- EPS past 5Y- ROI-51.40% 52W High-48.98% Beta-
Dividend %- Quick Ratio9.10 Sales past 5Y- Gross Margin- 52W Low192.33% ATR0.57
Employees290 Current Ratio9.10 Sales Q/Q0.00% Oper. Margin- RSI (14)45.52 Volatility6.35% 6.42%
OptionableNo Debt/Eq0.00 EPS Q/Q5.70% Profit Margin- Rel Volume0.73 Prev Close8.40
ShortableYes LT Debt/Eq0.00 EarningsNov 05 BMO Payout- Avg Volume175.36K Price8.77
Recom2.00 SMA20-1.95% SMA50-8.75% SMA200-27.00% Volume127,566 Change4.40%
Dec-28-20Resumed H.C. Wainwright Buy $19
Jul-31-20Initiated JP Morgan Overweight
Jul-22-20Initiated SunTrust Buy $38
Apr-22-20Initiated Mizuho Buy $18
Sep-23-19Initiated Needham Buy $26
May-17-19Reiterated H.C. Wainwright Buy $45 → $41
Oct-24-18Initiated H.C. Wainwright Buy $45
Jan-06-21 04:07AM  
Jan-04-21 07:00AM  
Dec-07-20 12:01PM  
Dec-05-20 03:01PM  
Dec-04-20 10:14AM  
Dec-01-20 08:55AM  
Nov-30-20 07:00AM  
Nov-17-20 07:00AM  
Nov-07-20 07:47AM  
Nov-06-20 05:30AM  
Nov-05-20 07:00AM  
Oct-30-20 07:00AM  
Sep-18-20 03:05AM  
Sep-08-20 07:00AM  
Sep-01-20 07:48AM  
Aug-06-20 07:00AM  
Aug-05-20 10:05AM  
Aug-04-20 07:00AM  
Jul-30-20 07:00AM  
Jul-02-20 04:39PM  
Jun-24-20 09:32AM  
Jun-22-20 07:00AM  
Jun-19-20 11:30AM  
Jun-12-20 02:30AM  
Jun-08-20 05:00PM  
Jun-03-20 06:28AM  
Jun-02-20 08:07AM  
May-29-20 07:37AM  
May-26-20 07:00AM  
May-22-20 07:00AM  
May-15-20 11:20AM  
May-14-20 07:00AM  
May-13-20 09:27AM  
May-12-20 12:00PM  
May-10-20 08:26AM  
May-09-20 11:01PM  
May-07-20 08:06AM  
May-01-20 07:00AM  
Apr-16-20 07:00AM  
Mar-03-20 07:07AM  
Feb-25-20 07:00AM  
Feb-24-20 07:00AM  
Jan-30-20 07:00AM  
Jan-27-20 04:00PM  
Jan-22-20 09:41PM  
Jan-13-20 07:00AM  
Jan-08-20 11:48AM  
Dec-20-19 06:30AM  
Dec-18-19 07:59AM  
Dec-14-19 07:47PM  
Dec-08-19 09:15AM  
Dec-07-19 02:00PM  
Dec-05-19 04:30PM  
Nov-27-19 07:03AM  
Nov-18-19 04:52AM  
Nov-13-19 04:02PM  
Nov-09-19 07:00AM  
Nov-07-19 07:06AM  
Nov-06-19 09:24AM  
Nov-05-19 09:35AM  
Oct-31-19 06:30AM  
Oct-30-19 07:01PM  
Oct-08-19 08:00AM  
Oct-03-19 09:08AM  
Sep-19-19 08:53AM  
Sep-16-19 10:34AM  
Sep-03-19 02:00AM  
Aug-28-19 04:05PM  
Aug-09-19 02:24AM  
Aug-08-19 07:49AM  
Aug-02-19 09:06AM  
Jul-16-19 10:31AM  
Jun-19-19 08:40AM  
May-28-19 04:55PM  
May-14-19 06:30AM  
May-07-19 04:05PM  
Apr-29-19 02:52PM  
Apr-23-19 07:49AM  
Apr-15-19 04:02PM  
Apr-12-19 08:50AM  
Apr-10-19 09:19PM  
Apr-08-19 04:40PM  
Apr-01-19 02:29PM  
Mar-29-19 04:05PM  
Mar-26-19 06:00AM  
Mar-07-19 04:05PM  
Mar-04-19 04:05PM  
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of hematological malignancies and solid tumors. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company was founded in 2014 and is headquartered in London, the United Kingdom.